Strategic partner Lyell Immunopharma led a $45m round for Eureka Therapeutics, which will use the money to advance a pipeline that includes a treatment for liver cancer.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Oura attracts $28m in series B funding
Google unit Gradient Ventures and Square have taken part in a $28m round for Oura, the developer of a wearable sleep tracker.
Genvid monetises $33m series B round
Huya, NTT Docomo Ventures and Samsung Ventures have provided a $6m extension for the livestreaming monetisation platform’s latest round.
StackPath packs up $216m
Edge computing network provider has pushed its total funding to $396m in a series B round co-led by Juniper Networks and Cox Communications.
Binance bankrolls $50m India fund
Binance and its Indian subsidiary WazirX intend to provide $50m in funding for blockchain technology developers following regulatory changes in the South Asian country.
From cancer to chicken nuggets
Cellular Agriculture was spun out of University of Bath in 2016 as the UK’s first startup in the cultured meat space, but its ambitions go far beyond a lab-grown burger.
Xirgo captures Owlcam in acquisition deal
Owlcam has been acquired by Xirgo Technologies for an undisclosed sum two years after emerging from stealth, having raised $28m from investors including CSAA.
RTL gets down to Bedrock
RTL has paid an undisclosed amount for a 50% stake in Bedrock, the vehicle through which M6 has spun off its catch-up television and streaming services.
Airwallex aims for $200m
The Tencent, Bank Central Asia and Mastercard-backed cross-border remittance service is seeking series D funding and is in talks with an unnamed financial services firm to lead the round.
Mastercard backs $125m Covid-19 accelerator
Covid-19 Therapeutics Accelerator has launched with $125m to find treatments for the pandemic, $25m of which came from Mastercard.
Kymera kits out $102m series C round
The immunotherapy developer, which counts Pfizer, Sanofi, Merck & Co, Eli Lilly, Amgen and Vertex Pharmaceuticals as early investors, has picked up $102m.
Albert accesses $50m in series B round
Personalised finance management service Albert secured $50m in a CapitalG-led round that included fellow corporate venturing vehicle American Express Ventures.
Lyra Health fires up $75m series C
Mental health services provider Lyra Health, whose earlier investors include Providence Health and Services and Castlight Health, has amassed $75m in its latest round.
Arctic Wolf packs in $60m
Blue Cloud Ventures and Stereo Capital co-led a series D round for the Sonae-backed cybersecurity services provider, pushing its total funding past the $150m mark.